Mavik¿ trandolapril tablets 4mg — Class III drug recall D-901-2013
Terminated recall by AbbVie Inc., reported 2013-08-28, distributed nationwide. Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
| Recall number | D-901-2013 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc., North Chicago, IL, United States |
| Recall initiated | 2013-08-01 |
| Classified | 2013-08-20 |
| Reported by FDA | 2013-08-28 |
| Terminated | 2013-11-07 |
| Distributed | Nationwide (US) |
| Quantity | 704 bottles |
| Reason classes | labeling |
| Lot numbers | 22033GY |
Product
Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA
Reason for recall
Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-901-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.